Overall survival (Fig. 1F), progression-free survival (Fig. 1G), and postprogression survival (Fig. 1H) were significantly lower in GC patients with high UBE4B expression than in those with low UBE4B expression (p < 0.001). The gene discussed is UBE4B; the disease is gastric cancer.